+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Organs-on-Chips - Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • October 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805906
The global market for Organs-on-Chips was estimated at US$67.2 Billion in 2023 and is projected to reach US$558.5 Billion by 2030, growing at a CAGR of 35.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

What Are Organs-on-Chips, and Why Are They Revolutionizing Biomedical Research?

Organs-on-chips are micro-engineered devices that mimic the functions and structures of human organs by combining living cells with advanced microfluidic systems. These devices are typically made from flexible, translucent materials that allow for real-time monitoring and analysis of cellular behavior, enabling researchers to study organ function and disease processes in a highly controlled environment. By simulating the physiological conditions of specific organs - such as the lung, liver, kidney, or heart - organs-on-chips offer a powerful alternative to traditional animal testing and cell cultures. The potential applications for organs-on-chips extend across drug discovery, disease modeling, and personalized medicine. Pharmaceutical companies and research institutions are using these devices to test drug efficacy and toxicity more accurately, reducing the reliance on animal models and increasing the precision of human-based studies. As personalized medicine gains prominence, the ability of organs-on-chips to model individual patient responses further highlights their potential to transform the field of biomedical research.

How Are Technological Innovations Advancing the Organs-on-Chips Industry?

The organs-on-chips market is experiencing rapid growth due to innovations in materials science, microfluidics, and tissue engineering. Advances in 3D bioprinting and microfabrication technologies have significantly enhanced the design and functionality of organs-on-chips, enabling the creation of more complex, multi-tissue models that can replicate not just individual organ functions, but also the interactions between different organs. These technological strides allow for the creation of interconnected organ systems, also known as 'body-on-a-chip' models, which better simulate the systemic effects of drugs and diseases in the human body. Further, developments in sensor technologies and imaging techniques are improving the ability to monitor cellular responses in real time, providing detailed insights into how drugs or disease processes affect human tissue at the cellular level. Researchers are also exploring the integration of artificial intelligence (AI) and machine learning algorithms to analyze data generated from organs-on-chips, enhancing predictive models for drug toxicity and therapeutic outcomes. These advances are accelerating the adoption of organs-on-chips in both academic research and industrial settings.

Where Are Organs-on-Chips Being Used Most Prominently?

Organs-on-chips are being used extensively in the pharmaceutical industry, academic research, and personalized medicine. Pharmaceutical companies are increasingly relying on these devices for drug discovery and preclinical testing, as they offer a more reliable and cost-effective way to evaluate drug safety and efficacy than traditional methods. The ability of organs-on-chips to replicate human organ responses with high fidelity makes them ideal for screening potential drug candidates and identifying toxic effects early in the development process. In academic and biomedical research, organs-on-chips are being employed to model a wide range of diseases, including cancer, cardiovascular conditions, and neurological disorders. These models allow researchers to investigate disease mechanisms and test new treatments in a human-relevant context. In personalized medicine, organs-on-chips are being explored as a tool for developing patient-specific therapies, where cells from individual patients can be used to create custom organ models that predict how they will respond to treatments. This is especially valuable for conditions such as cancer, where treatment responses can vary significantly between patients.

What Is Driving the Growth of the Organs-on-Chips Market?

The growth in the organs-on-chips market is driven by several factors, including the increasing demand for alternatives to animal testing, the rise of personalized medicine, and technological advancements in microfluidics and tissue engineering. One of the key drivers is the growing recognition that traditional animal models often fail to accurately predict human responses to drugs and diseases, creating a demand for more reliable, human-based testing platforms. Regulatory pressure to reduce animal testing, along with ethical concerns, has further fueled interest in organs-on-chips as a more humane and scientifically robust alternative. Additionally, the rise of personalized medicine, where treatments are tailored to individual patients, is driving demand for customized organ models that can predict patient-specific drug responses. Advances in microfabrication and tissue engineering are also expanding the capabilities of organs-on-chips, making them more versatile and accessible for a broader range of applications. Finally, increasing investment in biomedical research, coupled with collaborations between academic institutions, pharmaceutical companies, and government agencies, is accelerating the adoption and commercialization of organs-on-chips across the globe.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Liver-on-Chip segment, which is expected to reach US$206.0 Billion by 2030 with a CAGR of a 36.6%. The Kidney-on-Chip segment is also set to grow at 37.4% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was valued at $18.8 Billion in 2023, and China, forecasted to grow at an impressive 33.4% CAGR to reach $79.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Organs-on-Chips Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Organs-on-Chips Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Organs-on-Chips Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Ascendance Biotechnology, Inc., AxoSim, Inc., CN Bio Innovations Ltd., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 12 Featured):

  • Ascendance Biotechnology, Inc.
  • AxoSim, Inc.
  • CN Bio Innovations Ltd.
  • Emulate, Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall Ltd.
  • Mimetas
  • Nortis, Inc.
  • SynVivo
  • TissUse GmbH

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Organs-on-Chips - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Focus on Personalized Medicine and Drug Testing Spurs Growth in the Organs-on-Chips Market
  • Increasing R&D Investments in Biotechnology Strengthens Business Case for Organs-on-Chips in Drug Development
  • Advancements in Microfluidics and Tissue Engineering Propel Innovation in Organs-on-Chips Technology
  • Surge in Demand for Alternative Testing Methods Expands Market for Organs-on-Chips in Toxicity Testing
  • Rising Ethical Concerns Over Animal Testing Accelerates Adoption of Organs-on-Chips in Biomedical Research
  • Growing Application of Organs-on-Chips in Precision Medicine Expands Addressable Market for Personalized Drug Screening
  • Increasing Use of Organs-on-Chips in Disease Modeling Drives Growth in Research and Development
  • Advancements in 3D Bioprinting Technology Propel Innovation in Customizable Organs-on-Chips Platforms
  • Rising Demand for Predictive and High-Throughput Screening in Drug Discovery Fuels Adoption of Organs-on-Chips
  • Increasing Focus on Human Physiology Replication Strengthens Business Case for Organs-on-Chips in Preclinical Studies
  • Rising Use of Organs-on-Chips in Cardiovascular and Neurological Disease Studies Fuels Market Expansion
  • Increasing Application of Organs-on-Chips in Oncology and Cancer Research Propels Market Growth
  • Advancements in Integration of Sensors and Real-Time Data Analysis in Organs-on-Chips Drive Market Innovation
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Organs-on-Chips Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Organs-on-Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World 7-Year Perspective for Organs-on-Chips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World 7-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 6: World Recent Past, Current & Future Analysis for Kidney by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 7: World 7-Year Perspective for Kidney by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World 7-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World 7-Year Perspective for Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 12: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 13: World 7-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World 7-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 18: World Recent Past, Current & Future Analysis for Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 19: World 7-Year Perspective for Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 21: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 22: USA Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 23: USA 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
  • Table 24: USA Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 25: USA 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
CANADA
  • Table 26: Canada Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: Canada 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
  • Table 28: Canada Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 29: Canada 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
JAPAN
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 30: Japan Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 31: Japan 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
  • Table 32: Japan Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Japan 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
CHINA
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 34: China Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 35: China 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
  • Table 36: China Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 37: China 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
EUROPE
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 38: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 39: Europe 7-Year Perspective for Organs-on-Chips by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • Table 40: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 41: Europe 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
  • Table 42: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 43: Europe 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
FRANCE
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 44: France Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: France 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
  • Table 46: France Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 47: France 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
GERMANY
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 48: Germany Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 49: Germany 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
  • Table 50: Germany Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Germany 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
ITALY
  • Table 52: Italy Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 53: Italy 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
  • Table 54: Italy Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 55: Italy 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
UNITED KINGDOM
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 56: UK Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: UK 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
  • Table 58: UK Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 59: UK 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
REST OF EUROPE
  • Table 60: Rest of Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 61: Rest of Europe 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
  • Table 62: Rest of Europe Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Rest of Europe 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
ASIA-PACIFIC
  • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 64: Asia-Pacific Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 65: Asia-Pacific 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
  • Table 66: Asia-Pacific Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 67: Asia-Pacific 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
REST OF WORLD
  • Table 68: Rest of World Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Rest of World 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
  • Table 70: Rest of World Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 71: Rest of World 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ascendance Biotechnology, Inc.
  • AxoSim, Inc.
  • CN Bio Innovations Ltd.
  • Emulate, Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall Ltd.
  • Mimetas
  • Nortis, Inc.
  • SynVivo
  • TissUse GmbH

Table Information